Clover Health Investments
CLOV
148 hedge funds and large institutions have $1.89B invested in Clover Health Investments in 2021 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 29 increasing their positions, 34 reducing their positions, and 50 closing their positions.
98% more call options, than puts
Call options by funds: $366M | Put options by funds: $185M
20% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 50
7% more funds holding
Funds holding: 138 → 148 (+10)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 34
15.8% less ownership
Funds ownership: 111.56% → 95.76% (-16%)
68% less capital inflows, than outflows
Capital inflows: $75M | Capital outflows: $238M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bloom Tree Partners
New York
|
+$9.7M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.48M |
| 3 |
State Street
Boston,
Massachusetts
|
+$7.13M |
| 4 |
Morgan Stanley
New York
|
+$6.93M |
| 5 |
GAM Holding
Zurich,
Switzerland
|
+$6.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$164M |
| 2 |
Senator Investment Group
New York
|
-$37.8M |
| 3 |
Lakewood Capital Management
New York
|
-$6.65M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$2.93M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.37M |
CLOV Hedge Fund Activity: Q2 2021 in Review
148 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q2 2021, worth a combined $1.89B — up 57% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new CLOV positions and 50 closed out — a net gain of 10 holders — while 29 added to existing stakes and 34 trimmed.
The largest buyer was Bloom Tree Partners, opening a new position worth an estimated $9.7M. The largest seller was Vanguard Group, cutting an estimated $164M.
- 148 institutional investors held Clover Health Investments (CLOV) as of Q2 2021, up from 138 in Q1 2021.
- Funds reported $1.89B of Clover Health Investments stock for Q2 2021, up 57% quarter-over-quarter.
- 60 funds opened new Clover Health Investments positions in Q2 2021 and 50 closed out, a net change of +10 holders.
- The largest Clover Health Investments buyer in Q2 2021 was Bloom Tree Partners, an estimated $9.7M added.
- The largest Clover Health Investments seller in Q2 2021 was Vanguard Group, an estimated $164M sold.
Based on aggregated 13F filings for Q2 2021.